Why the FDA’s top spot could sit empty for months

Multiple factors could get in the way of confirming a new commissioner before the midterm elections, experts said, leaving the agency’s long-term initiatives in limbo.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top